<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34200161</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Overexpression of miR-124 in Motor Neurons Plays a Key Role in ALS Pathological Processes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6128</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22116128</ELocationID><Abstract><AbstractText>miRNA(miR)-124 is an important regulator of neurogenesis, but its upregulation in SOD1G93A motor neurons (mSOD1 MNs) was shown to associate with neurodegeneration and microglia activation. We used pre-miR-124 in wild-type (WT) MNs and anti-miR-124 in mSOD1 MNs to characterize the miR-124 pathological role. miR-124 overexpression in WT MNs produced a miRNA profile like that of mSOD1 MNs (high miR-125b; low miR-146a and miR-21), and similarly led to early apoptosis. Alterations in mSOD1 MNs were abrogated with anti-miR-124 and changes in their miRNAs mostly recapitulated by their secretome. Normalization of miR-124 levels in mSOD1 MNs prevented the dysregulation of neurite network, mitochondria dynamics, axonal transport, and synaptic signaling. Same alterations were observed in WT MNs after pre-miR-124 transfection. Secretome from mSOD1 MNs triggered spinal microglia activation, which was unno-ticed with that from anti-miR-124-modulated cells. Secretome from such modulated MNs, when added to SC organotypic cultures from mSOD1 mice in the early symptomatic stage, also coun-teracted the pathology associated to GFAP decrease, PSD-95 and CX3CL1-CX3CR1 signaling im-pairment, neuro-immune homeostatic imbalance, and enhanced miR-124 expression levels. Data suggest that miR-124 is implicated in MN degeneration and paracrine-mediated pathogenicity. We propose miR-124 as a new therapeutic target and a promising ALS biomarker in patient sub-populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaz</LastName><ForeName>Ana Rita</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0002-3418-3269</Identifier><AffiliationInfo><Affiliation>Neuroinflammation, Signaling and Neuroregeneration Group, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences and Medicines, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vizinha</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neuroinflammation, Signaling and Neuroregeneration Group, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morais</LastName><ForeName>Hermes</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Neuroinflammation, Signaling and Neuroregeneration Group, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cola&#xe7;o</LastName><ForeName>Ana Rita</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Neuroinflammation, Signaling and Neuroregeneration Group, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loch-Neckel</LastName><ForeName>Gecioni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neuroinflammation, Signaling and Neuroregeneration Group, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1735-3251</Identifier><AffiliationInfo><Affiliation>Neuroinflammation, Signaling and Neuroregeneration Group, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brites</LastName><ForeName>Dora</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3024-9777</Identifier><AffiliationInfo><Affiliation>Neuroinflammation, Signaling and Neuroregeneration Group, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences and Medicines, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PTDC/MED-NEU/31395/2017</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e a Tecnologia</Agency><Country/></Grant><Grant><GrantID>UIDB/04138/2020</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e a Tecnologia</Agency><Country/></Grant><Grant><GrantID>UIDP/04138/2020</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e a Tecnologia</Agency><Country/></Grant><Grant><GrantID>LISBOA- 01-0145</GrantID><Agency>Programa Operacional Regional de Lisboa</Agency><Country/></Grant><Grant><GrantID>FEDER-031395</GrantID><Agency>Programa Operacional Competitividade e Internacionaliza&#xe7;&#xe3;o</Agency><Country/></Grant><Grant><GrantID>ELA-2015-002</GrantID><Agency>Santa Casa da Miseric&#xf3;rdia de Lisboa</Agency><Country/></Grant><Grant><GrantID>SFRH/BD/129586/2017</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e a Tecnologia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C540079">Mirn124 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">inflamma-miRNAs</Keyword><Keyword MajorTopicYN="N">mSOD1 mice model</Keyword><Keyword MajorTopicYN="N">miR-124 modulation</Keyword><Keyword MajorTopicYN="N">motor neuron regeneration</Keyword><Keyword MajorTopicYN="N">motor neuron secretome</Keyword><Keyword MajorTopicYN="N">neuro-immune deregulation</Keyword><Keyword MajorTopicYN="N">paracrine signaling regulation</Keyword><Keyword MajorTopicYN="N">spinal microglia</Keyword><Keyword MajorTopicYN="N">spinal organotypic cultures</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study, either in the collection, analyses and interpretation of data, or in the writing of the manuscript and in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34200161</ArticleId><ArticleId IdType="pmc">PMC8201298</ArticleId><ArticleId IdType="doi">10.3390/ijms22116128</ArticleId><ArticleId IdType="pii">ijms22116128</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khalid S.I., Ampie L., Kelly R., Ladha S.S., Dardis C. Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials. Front. Neurol. 2017;8:486. doi: 10.3389/fneur.2017.00486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00486</ArticleId><ArticleId IdType="pmc">PMC5622209</ArticleId><ArticleId IdType="pubmed">28993751</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites D., Vaz A.R. Microglia centered pathogenesis in ALS: Insights in cell interconnectivity. Front. Cell Neurosci. 2014;8:117. doi: 10.3389/fncel.2014.00117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00117</ArticleId><ArticleId IdType="pmc">PMC4033073</ArticleId><ArticleId IdType="pubmed">24904276</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha C., Santos C., Gomes C., Fernandes A., Correia A.M., Sebasti&#xe3;o A.M., Vaz A.R., Brites D. Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage. Mol. Neurobiol. 2018;55:4207&#x2013;4224. doi: 10.1007/s12035-017-0631-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0631-2</ArticleId><ArticleId IdType="pubmed">28612258</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Cunha C., Nascimento F., Ribeiro J.A., Vaz A.R., Brites D. Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model. Mol. Neurobiol. 2019;56:2137&#x2013;2158. doi: 10.1007/s12035-018-1220-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1220-8</ArticleId><ArticleId IdType="pubmed">29995256</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrafiah A.R. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis. In Vivo. 2018;32:983&#x2013;998. doi: 10.21873/invivo.11339.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.11339</ArticleId><ArticleId IdType="pmc">PMC6199613</ArticleId><ArticleId IdType="pubmed">30150420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P.J. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011;7:616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Bento-Abreu A., Van Damme P., Van Den Bosch L., Robberecht W. The neurobiology of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2010;31:2247&#x2013;2265. doi: 10.1111/j.1460-9568.2010.07260.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2010.07260.x</ArticleId><ArticleId IdType="pubmed">20529130</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Robberecht W., Van Den Bosch L. Modelling amyotrophic lateral sclerosis: Progress and possibilities. Dis. Model Mech. 2017;10:537&#x2013;549. doi: 10.1242/dmm.029058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029058</ArticleId><ArticleId IdType="pmc">PMC5451175</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites D. Regulatory function of microRNAs in microglia. Glia. 2020;68:1631&#x2013;1642. doi: 10.1002/glia.23846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23846</ArticleId><ArticleId IdType="pubmed">32463968</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Jedrychowski M.P., Cialic R., Krasemann S., Murugaiyan G., Fanek Z., Greco D.J., Wu P.M., Doykan C.E., Kiner O., et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann. Neurol. 2015;77:75&#x2013;99. doi: 10.1002/ana.24304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24304</ArticleId><ArticleId IdType="pmc">PMC4432483</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D., Droppelmann C.A., He Z., Volkening K., Strong M.J. Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: A role in the regulation of NFL mRNA levels. Mol. Brain. 2013;6:26. doi: 10.1186/1756-6606-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-26</ArticleId><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Foggin S., Mesquita-Ribeiro R., Dajas-Bailador F., Layfield R. Biological Significance of microRNA Biomarkers in ALS-Innocent Bystanders or Disease Culprits? Front. Neurol. 2019;10:578. doi: 10.3389/fneur.2019.00578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00578</ArticleId><ArticleId IdType="pmc">PMC6579821</ArticleId><ArticleId IdType="pubmed">31244752</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Lunn J.S., Paez-Colasante X., Bender D.E., Yung R., Sakowski S.A., Feldman E.L. Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol. Cell Neurosci. 2016;71:34&#x2013;45. doi: 10.1016/j.mcn.2015.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.12.008</ArticleId><ArticleId IdType="pmc">PMC4761498</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Luo Z.M., Guo X.M., Su D.F., Liu X. An updated role of microRNA-124 in central nervous system disorders: A review. Front. Cell Neurosci. 2015;9:193. doi: 10.3389/fncel.2015.00193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00193</ArticleId><ArticleId IdType="pmc">PMC4438253</ArticleId><ArticleId IdType="pubmed">26041995</ArticleId></ArticleIdList></Reference><Reference><Citation>Neo W.H., Yap K., Lee S.H., Looi L.S., Khandelia P., Neo S.X., Makeyev E.V., Su I.H. MicroRNA miR-124 controls the choice between neuronal and astrocyte differentiation by fine-tuning Ezh2 expression. J. Biol. Chem. 2014;289:20788&#x2013;20801. doi: 10.1074/jbc.M113.525493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.525493</ArticleId><ArticleId IdType="pmc">PMC4110287</ArticleId><ArticleId IdType="pubmed">24878960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponomarev E.D., Veremeyko T., Barteneva N., Krichevsky A.M., Weiner H.L. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat. Med. 2011;17:64&#x2013;70. doi: 10.1038/nm.2266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2266</ArticleId><ArticleId IdType="pmc">PMC3044940</ArticleId><ArticleId IdType="pubmed">21131957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponomarev E.D., Veremeyko T., Weiner H.L. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia. 2013;61:91&#x2013;103. doi: 10.1002/glia.22363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22363</ArticleId><ArticleId IdType="pmc">PMC3434289</ArticleId><ArticleId IdType="pubmed">22653784</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel L., Regan M., Higashimori H., Ng S.K., Esau C., Vidensky S., Rothstein J., Yang Y. Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J. Biol. Chem. 2013;288:7105&#x2013;7116. doi: 10.1074/jbc.M112.410944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.410944</ArticleId><ArticleId IdType="pmc">PMC3591620</ArticleId><ArticleId IdType="pubmed">23364798</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Zhang C., Guan Y., Chen Y., Lu Q., Jie L., Gao H., Du H., Zhang H., Liu Y., et al. Screening the expression characteristics of several miRNAs in G93A-SOD1 transgenic mouse: Altered expression of miRNA-124 is associated with astrocyte differentiation by targeting Sox2 and Sox9. J. Neurochem. 2018;145:51&#x2013;67. doi: 10.1111/jnc.14229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14229</ArticleId><ArticleId IdType="pubmed">28960306</ArticleId></ArticleIdList></Reference><Reference><Citation>Yardeni T., Fine R., Joshi Y., Gradus-Pery T., Kozer N., Reichenstein I., Yanowski E., Nevo S., Weiss-Tishler H., Eisenberg-Bord M., et al. High content image analysis reveals function of miR-124 upstream of Vimentin in regulating motor neuron mitochondria. Sci. Rep. 2018;8:59. doi: 10.1038/s41598-017-17878-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17878-x</ArticleId><ArticleId IdType="pmc">PMC5758812</ArticleId><ArticleId IdType="pubmed">29311649</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S., Bonanno S., Kapetis D., Barzago C., Cavalcante P., D&#x2019;Alessandro S., Mantegazza R., Bernasconi P. Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage. Mol. Brain. 2015;8:5. doi: 10.1186/s13041-015-0095-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0095-0</ArticleId><ArticleId IdType="pmc">PMC4318136</ArticleId><ArticleId IdType="pubmed">25626686</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C., Arisi I., D&#x2019;Ambrosi N., Storti A.E., Brandi R., D&#x2019;Onofrio M., Volonte C. Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation. Cell Death Dis. 2013;4:e959. doi: 10.1038/cddis.2013.491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.491</ArticleId><ArticleId IdType="pmc">PMC3877562</ArticleId><ArticleId IdType="pubmed">24336079</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Wyles M., Heath P.R., Kazoka M., Wollff H., Shaw P.J., Kirby J. Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity. Front. Neurosci. 2017;11:731. doi: 10.3389/fnins.2017.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00731</ArticleId><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelick J., Men Y., Jin S., Seo S., Espejo-Porras F., Yang Y. Elevated exosomal secretion of miR-124&#x2013;3p from spinal neurons positively associates with disease severity in ALS. Exp. Neurol. 2020;333:113414. doi: 10.1016/j.expneurol.2020.113414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113414</ArticleId><ArticleId IdType="pmc">PMC7502520</ArticleId><ArticleId IdType="pubmed">32712030</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S., Cunha C., Barbosa M., Vaz A.R., Brites D. Exosomes from NSC-34 Cells Transfected with hSOD1-G93A Are Enriched in miR-124 and Drive Alterations in Microglia Phenotype. Front. Neurosci. 2017;11:273. doi: 10.3389/fnins.2017.00273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00273</ArticleId><ArticleId IdType="pmc">PMC5434170</ArticleId><ArticleId IdType="pubmed">28567000</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz A.R., Cunha C., Gomes C., Schmucki N., Barbosa M., Brites D. Glycoursodeoxycholic acid reduces matrix metalloproteinase-9 and caspase-9 activation in a cellular model of superoxide dismutase-1 neurodegeneration. Mol. Neurobiol. 2015;51:864&#x2013;877. doi: 10.1007/s12035-014-8731-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8731-8</ArticleId><ArticleId IdType="pubmed">24848512</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldeira C., Oliveira A.F., Cunha C., Vaz A.R., Falc&#xe3;o A.S., Fernandes A., Brites D. Microglia change from a reactive to an age-like phenotype with the time in culture. Front. Cell Neurosci. 2014;8:152. doi: 10.3389/fncel.2014.00152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00152</ArticleId><ArticleId IdType="pmc">PMC4040822</ArticleId><ArticleId IdType="pubmed">24917789</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthod F., Gros-Louis F. In Vivo and In Vitro Models to Study Amyotrophic Lateral Sclerosis. In: Maurer M.H., editor. Amyotrophic Lateral Sclerosis (ALS) IntechOpen; London, UK: 2012. Chapter 4.</Citation></Reference><Reference><Citation>Hayden P.J., Harbell J.W. Special review series on 3D organotypic culture models: Introduction and historical perspective. Vitro Cell Dev. Biol. Anim. 2021;57:95&#x2013;103. doi: 10.1007/s11626-020-00500-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11626-020-00500-2</ArticleId><ArticleId IdType="pmc">PMC7687207</ArticleId><ArticleId IdType="pubmed">33237402</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J.Y., Chung K.H., Deo M., Thompson R.C., Turner D.L. MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp. Cell Res. 2008;314:2618&#x2013;2633. doi: 10.1016/j.yexcr.2008.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2008.06.002</ArticleId><ArticleId IdType="pmc">PMC2702206</ArticleId><ArticleId IdType="pubmed">18619591</ArticleId></ArticleIdList></Reference><Reference><Citation>Han D., Dong X., Zheng D., Nao J. MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders. Front. Pharmacol. 2019;10:1555. doi: 10.3389/fphar.2019.01555.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01555</ArticleId><ArticleId IdType="pmc">PMC6978711</ArticleId><ArticleId IdType="pubmed">32009959</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.Y., Kim Y.R., Choi K.W., Lee M., Lee S., Im W., Shin J.Y., Kim J.Y., Hong Y.H., Kim M., et al. Downregulated miR-18b-5p triggers apoptosis by inhibition of calcium signaling and neuronal cell differentiation in transgenic SOD1 (G93A) mice and SOD1 (G17S and G86S) ALS patients. Transl. Neurodegener. 2020;9:23. doi: 10.1186/s40035-020-00203-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-020-00203-4</ArticleId><ArticleId IdType="pmc">PMC7328278</ArticleId><ArticleId IdType="pubmed">32605607</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho G.W., Kim G.Y., Baek S., Kim H., Kim T., Kim H.J., Kim S.H. Recombinant human erythropoietin reduces aggregation of mutant Cu/Zn-binding superoxide dismutase (SOD1) in NSC-34 cells. Neurosci. Lett. 2011;504:107&#x2013;111. doi: 10.1016/j.neulet.2011.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2011.09.008</ArticleId><ArticleId IdType="pubmed">21945651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Q., Ruan H., Gilbert J., Wang G., Ma Q., Yao W.D., Man H.Y. MicroRNA miR124 is required for the expression of homeostatic synaptic plasticity. Nat. Commun. 2015;6:10045. doi: 10.1038/ncomms10045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10045</ArticleId><ArticleId IdType="pmc">PMC4686673</ArticleId><ArticleId IdType="pubmed">26620774</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Z., Wang P.Y., Su D.F., Liu X. miRNA-124 in Immune System and Immune Disorders. Front. Immunol. 2016;7:406. doi: 10.3389/fimmu.2016.00406.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00406</ArticleId><ArticleId IdType="pmc">PMC5047895</ArticleId><ArticleId IdType="pubmed">27757114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge X.T., Lei P., Wang H.C., Zhang A.L., Han Z.L., Chen X., Li S.H., Jiang R.C., Kang C.S., Zhang J.N. miR-21 improves the neurological outcome after traumatic brain injury in rats. Sci. Rep. 2014;4:6718. doi: 10.1038/srep06718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep06718</ArticleId><ArticleId IdType="pmc">PMC4208064</ArticleId><ArticleId IdType="pubmed">25342226</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Lasso D.C., Roma-Mateo C., Pallardo F.V., Gonzalez-Cabo P. Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders. Cells. 2020;9:358. doi: 10.3390/cells9020358.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9020358</ArticleId><ArticleId IdType="pmc">PMC7072452</ArticleId><ArticleId IdType="pubmed">32033020</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruangjaroon T., Chokchaichamnankit D., Srisomsap C., Svasti J., Paricharttanakul N.M. Involvement of vimentin in neurite outgrowth damage induced by fipronil in SH-SY5Y cells. Biochem. Biophys. Res. Commun. 2017;486:652&#x2013;658. doi: 10.1016/j.bbrc.2017.03.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.03.081</ArticleId><ArticleId IdType="pubmed">28322794</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilokani L., Nagashima S., Paupe V., Prudent J. Mitochondrial dynamics: Overview of molecular mechanisms. Essays Biochem. 2018;62:341&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6056715</ArticleId><ArticleId IdType="pubmed">30030364</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Yamashita T., Tian F., Morimoto N., Ikeda Y., Deguchi K., Abe K. Mitochondrial fusion and fission proteins expression dynamically change in a murine model of amyotrophic lateral sclerosis. Curr. Neurovasc. Res. 2013;10:222&#x2013;230. doi: 10.2174/15672026113109990060.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/15672026113109990060</ArticleId><ArticleId IdType="pubmed">23713734</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermann B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 2010;11:872&#x2013;884. doi: 10.1038/nrm3013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3013</ArticleId><ArticleId IdType="pubmed">21102612</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.J., McIntyre R.L., Janssens G.E., Houtkooper R.H. Mitochondrial fission and fusion: A dynamic role in aging and potential target for age-related disease. Mech. Ageing Dev. 2020;186:111212. doi: 10.1016/j.mad.2020.111212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2020.111212</ArticleId><ArticleId IdType="pubmed">32017944</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa M., Gomes C., Sequeira C., Goncalves-Ribeiro J., Pina C.C., Carvalho L.A., Moreira R., Vaz S.H., Vaz A.R., Brites D. Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons. Front. Cell Dev. Biol. 2021;9:634355. doi: 10.3389/fcell.2021.634355.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.634355</ArticleId><ArticleId IdType="pmc">PMC8103001</ArticleId><ArticleId IdType="pubmed">33968923</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner B.J., Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 2008;85:94&#x2013;134. doi: 10.1016/j.pneurobio.2008.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.01.001</ArticleId><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavaliere F., Benito-Munoz M., Matute C. Organotypic Cultures as a Model to Study Adult Neurogenesis in CNS Disorders. Stem. Cells Int. 2016;2016:3540568. doi: 10.1155/2016/3540568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/3540568</ArticleId><ArticleId IdType="pmc">PMC4835641</ArticleId><ArticleId IdType="pubmed">27127518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lossi L., Merighi A. The Use of ex Vivo Rodent Platforms in Neuroscience Translational Research With Attention to the 3Rs Philosophy. Front. Vet. Sci. 2018;5:164. doi: 10.3389/fvets.2018.00164.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2018.00164</ArticleId><ArticleId IdType="pmc">PMC6060265</ArticleId><ArticleId IdType="pubmed">30073174</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew M.V. Astrocyte Reactivity: Subtypes, States, and Functions in CNS Innate Immunity. Trends Immunol. 2020;41:758&#x2013;770. doi: 10.1016/j.it.2020.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.07.004</ArticleId><ArticleId IdType="pmc">PMC7484257</ArticleId><ArticleId IdType="pubmed">32819810</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopperton K.E., Mohammad D., Trepanier M.O., Giuliano V., Bazinet R.P. Markers of microglia in post-mortem brain samples from patients with Alzheimer&#x2019;s disease: A systematic review. Mol. Psychiatry. 2018;23:177&#x2013;198. doi: 10.1038/mp.2017.246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2017.246</ArticleId><ArticleId IdType="pmc">PMC5794890</ArticleId><ArticleId IdType="pubmed">29230021</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Amarilla P., Olivera-Bravo S., Trias E., Cragnolini A., Martinez-Palma L., Cassina P., Beckman J., Barbeito L. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2011;108:18126&#x2013;18131. doi: 10.1073/pnas.1110689108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Staal J.A., Alexander S.R., Liu Y., Dickson T.D., Vickers J.C. Characterization of cortical neuronal and glial alterations during culture of organotypic whole brain slices from neonatal and mature mice. PLoS ONE. 2011;6:e22040. doi: 10.1371/journal.pone.0022040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022040</ArticleId><ArticleId IdType="pmc">PMC3137607</ArticleId><ArticleId IdType="pubmed">21789209</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Prieto M., Gutierrez I.L., Garcia-Bueno B., Caso J.R., Leza J.C., Ortega-Hernandez A., Gomez-Garre D., Madrigal J.L.M. MicroglialCX3CR1production increases in Alzheimer&#x2019;s disease and is regulated by noradrenaline. Glia. 2021;69:73&#x2013;90. doi: 10.1002/glia.23885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23885</ArticleId><ArticleId IdType="pubmed">32662924</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Sequeira C., Barbosa M., Cunha C., Vaz A.R., Brites D. Astrocyte regional diversity in ALS includes distinct aberrant phenotypes with common and causal pathological processes. Exp. Cell Res. 2020;395:112209. doi: 10.1016/j.yexcr.2020.112209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2020.112209</ArticleId><ArticleId IdType="pubmed">32739211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002;12:735&#x2013;739. doi: 10.1016/S0960-9822(02)00809-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(02)00809-6</ArticleId><ArticleId IdType="pubmed">12007417</ArticleId></ArticleIdList></Reference><Reference><Citation>Krichevsky A.M., King K.S., Donahue C.P., Khrapko K., Kosik K.S. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 2003;9:1274&#x2013;1281. doi: 10.1261/rna.5980303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.5980303</ArticleId><ArticleId IdType="pmc">PMC1370491</ArticleId><ArticleId IdType="pubmed">13130141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafouri-Fard S., Shoorei H., Bahroudi Z., Abak A., Majidpoor J., Taheri M. An update on the role of miR-124 in the pathogenesis of human disorders. Biomed. Pharmacother. 2021;135:111198. doi: 10.1016/j.biopha.2020.111198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.111198</ArticleId><ArticleId IdType="pubmed">33412388</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Yan M., Chen C., Gong W., Yin Z., Li H., Fan J., Zhang X.A., Wang D.W., Zuo H. MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart. Oncotarget. 2018;9:14382&#x2013;14396. doi: 10.18632/oncotarget.24205.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.24205</ArticleId><ArticleId IdType="pmc">PMC5865677</ArticleId><ArticleId IdType="pubmed">29581851</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuokila N., Lukasiuk K., Bot A.M., van Vliet E.A., Aronica E., Pitkanen A., Puhakka N. miR-124&#x2013;3p is a chronic regulator of gene expression after brain injury. Cell Mol. Life Sci. 2018;75:4557&#x2013;4581. doi: 10.1007/s00018-018-2911-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2911-z</ArticleId><ArticleId IdType="pubmed">30155647</ArticleId></ArticleIdList></Reference><Reference><Citation>An F.M., Gong G.H., Wang Y., Bian M., Yu L.J., Wei C.X. MiR-124 acts as a target for Alzheimer&#x2019;s disease by regulating BACE1. Oncotarget. 2017;8:114065&#x2013;114071. doi: 10.18632/oncotarget.23119.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.23119</ArticleId><ArticleId IdType="pmc">PMC5768386</ArticleId><ArticleId IdType="pubmed">29371969</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell E., Taylor M.A. Functional Roles for Exosomal MicroRNAs in the Tumour Microenvironment. Comput. Struct. Biotechnol. J. 2017;15:8&#x2013;13. doi: 10.1016/j.csbj.2016.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2016.10.005</ArticleId><ArticleId IdType="pmc">PMC5109280</ArticleId><ArticleId IdType="pubmed">27872688</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz Quiroz J.F., Tsai E., Coyle M., Sehm T., Echeverri K. Precise control of miR-125b levels is required to create a regeneration-permissive environment after spinal cord injury: A cross-species comparison between salamander and rat. Dis. Model Mech. 2014;7:601&#x2013;611. doi: 10.1242/dmm.014837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.014837</ArticleId><ArticleId IdType="pmc">PMC4036468</ArticleId><ArticleId IdType="pubmed">24719025</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer D., Neilson J.R., Foster K.A., Wang C.F., Seeburg D.P., Batterton M.N., Tada T., Dolan B.M., Sharp P.A., Sheng M. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron. 2010;65:373&#x2013;384. doi: 10.1016/j.neuron.2010.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.01.005</ArticleId><ArticleId IdType="pmc">PMC5018398</ArticleId><ArticleId IdType="pubmed">20159450</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison E.B., Hochfelder C.G., Lamberty B.G., Meays B.M., Morsey B.M., Kelso M.L., Fox H.S., Yelamanchili S.V. Traumatic brain injury increases levels of miR-21 in extracellular vesicles: Implications for neuroinflammation. FEBS Open Bio. 2016;6:835&#x2013;846. doi: 10.1002/2211-5463.12092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.12092</ArticleId><ArticleId IdType="pmc">PMC4971839</ArticleId><ArticleId IdType="pubmed">27516962</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes A., Ribeiro A.R., Monteiro M., Garcia G., Vaz A.R., Brites D. Secretome from SH-SY5Y APP Swe cells trigger time-dependent CHME3 microglia activation phenotypes, ultimately leading to miR-21 exosome shuttling. Biochimie. 2018;155:67&#x2013;82. doi: 10.1016/j.biochi.2018.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2018.05.015</ArticleId><ArticleId IdType="pubmed">29857185</ArticleId></ArticleIdList></Reference><Reference><Citation>Strickland I.T., Richards L., Holmes F.E., Wynick D., Uney J.B., Wong L.F. Axotomy-induced miR-21 promotes axon growth in adult dorsal root ganglion neurons. PLoS ONE. 2011;6:e23423. doi: 10.1371/journal.pone.0023423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023423</ArticleId><ArticleId IdType="pmc">PMC3154476</ArticleId><ArticleId IdType="pubmed">21853131</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Q., Yu C., Wang Y., Liu L., Zhang K., Fang C., Liu F., Bian G., Song B., Yang A., et al. miR-9 and miR-124 synergistically affect regulation of dendritic branching via the AKT/GSK3beta pathway by targeting Rap2a. Sci. Rep. 2016;6:26781. doi: 10.1038/srep26781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep26781</ArticleId><ArticleId IdType="pmc">PMC4879704</ArticleId><ArticleId IdType="pubmed">27221778</ArticleId></ArticleIdList></Reference><Reference><Citation>Osking Z., Ayers J.I., Hildebrandt R., Skruber K., Brown H., Ryu D., Eukovich A.R., Golde T.E., Borchelt D.R., Read T.A., et al. ALS-Linked SOD1 Mutants Enhance Neurite Outgrowth and Branching in Adult Motor Neurons. iScience. 2019;19:448&#x2013;449. doi: 10.1016/j.isci.2019.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2019.08.004</ArticleId><ArticleId IdType="pmc">PMC6708981</ArticleId><ArticleId IdType="pubmed">31425915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Huang Y., Wang L.-L., Zhang Y.-F., Xu J., Zhou Y., Lourenco G.F., Zhang B., Wang Y., Ren R.-J., et al. MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer&#x2019;s disease. Sci. Rep. 2016;6:26697. doi: 10.1038/srep26697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep26697</ArticleId><ArticleId IdType="pmc">PMC4879631</ArticleId><ArticleId IdType="pubmed">27221467</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto R.G., Amin M.Y., Deyoung D., Hey M., Mareci T.H., Magin R.L. Ultra-High Field Diffusion MRI Reveals Early Axonal Pathology in Spinal Cord of ALS mice. Transl. Neurodegener. 2018;7:20. doi: 10.1186/s40035-018-0122-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-018-0122-z</ArticleId><ArticleId IdType="pmc">PMC6097419</ArticleId><ArticleId IdType="pubmed">30128146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayia L.C., Tadi P. StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2021. Neuroanatomy, Motor Neuron.</Citation></Reference><Reference><Citation>Nagata K., Hama I., Kiryu-Seo S., Kiyama H. microRNA-124 is down regulated in nerve-injured motor neurons and it potentially targets mRNAs for KLF6 and STAT3. Neuroscience. 2014;256:426&#x2013;432. doi: 10.1016/j.neuroscience.2013.10.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.10.055</ArticleId><ArticleId IdType="pubmed">24184980</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley Z.C.E., Campos-Melo D., Droppelmann C.A., Strong M.J. MotomiRs: miRNAs in Motor Neuron Function and Disease. Front. Mol. Neurosci. 2017;10:127. doi: 10.3389/fnmol.2017.00127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00127</ArticleId><ArticleId IdType="pmc">PMC5415563</ArticleId><ArticleId IdType="pubmed">28522960</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen&#xe7; B., Jara J.H., Lagrimas A.K., Pytel P., Roos R.P., Mesulam M.M., Geula C., Bigio E.H., Ozdinler P.H. Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS. Sci. Rep. 2017;7:41765. doi: 10.1038/srep41765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41765</ArticleId><ArticleId IdType="pmc">PMC5292972</ArticleId><ArticleId IdType="pubmed">28165465</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., Hafezparast M. Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research? Neurobiol. Dis. 2017;105:283&#x2013;299. doi: 10.1016/j.nbd.2017.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.02.004</ArticleId><ArticleId IdType="pmc">PMC5536153</ArticleId><ArticleId IdType="pubmed">28235672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Warita H., Itoyama Y., Abe K. Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res. 1999;819:120&#x2013;131. doi: 10.1016/S0006-8993(98)01351-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(98)01351-1</ArticleId><ArticleId IdType="pubmed">10082867</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., Chapman A.L., Tennant M.E., Manser C., Tudor E.L., Lau K.F., Brownlees J., Ackerley S., Shaw P.J., McLoughlin D.M., et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 2007;16:2720&#x2013;2728. doi: 10.1093/hmg/ddm226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm226</ArticleId><ArticleId IdType="pmc">PMC4516806</ArticleId><ArticleId IdType="pubmed">17725983</ArticleId></ArticleIdList></Reference><Reference><Citation>Delic V., Kurien C., Cruz J., Zivkovic S., Barretta J., Thomson A., Hennessey D., Joseph J., Ehrhart J., Willing A.E., et al. Discrete mitochondrial aberrations in the spinal cord of sporadic ALS patients. J. Neurosci. Res. 2018;96:1353&#x2013;1366. doi: 10.1002/jnr.24249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24249</ArticleId><ArticleId IdType="pubmed">29732581</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E., Colombrita C., Gumina V., Borghi M.O., Dusi S., Doretti A., Fagiolari G., Invernizzi F., Moggio M., Tiranti V., et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol. Commun. 2016;4:47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrane J., Cortez C., Gan W.B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A.U., Saw N.L., Vogel H., Cunnigham A.D., Shamloo M., Mochly-Rosen D. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. EMBO Mol. Med. 2018;10:e8166. doi: 10.15252/emmm.201708166.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708166</ArticleId><ArticleId IdType="pmc">PMC5840540</ArticleId><ArticleId IdType="pubmed">29335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Yan L., Jiang X., Yu Y., Liu H., Gu T., Shi E. Acquired inhibition of microRNA-124 protects against spinal cord ischemia-reperfusion injury partially through a mitophagy-dependent pathway. J. Thorac. Cardiovasc. Surg. 2017;154:1498&#x2013;1508. doi: 10.1016/j.jtcvs.2017.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.05.046</ArticleId><ArticleId IdType="pubmed">28623098</ArticleId></ArticleIdList></Reference><Reference><Citation>Veremeyko T., Kuznetsova I.S., Dukhinova M., Yung A.W.Y., Kopeikina E., Barteneva N.S., Ponomarev E.D. Neuronal extracellular microRNAs miR-124 and miR-9 mediate cell-cell communication between neurons and microglia. J. Neurosci. Res. 2019;97:162&#x2013;184. doi: 10.1002/jnr.24344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24344</ArticleId><ArticleId IdType="pmc">PMC6587827</ArticleId><ArticleId IdType="pubmed">30367726</ArticleId></ArticleIdList></Reference><Reference><Citation>Zullo J., Matsumoto K., Xavier S., Ratliff B., Goligorsky M.S. The cell secretome, a mediator of cell-to-cell communication. Prostaglandins Lipid Mediat. 2015;120:17&#x2013;20. doi: 10.1016/j.prostaglandins.2015.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prostaglandins.2015.03.012</ArticleId><ArticleId IdType="pmc">PMC4575600</ArticleId><ArticleId IdType="pubmed">25936481</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K., Kaspar B.K. Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish. Brain Res. 2017;1656:27&#x2013;39. doi: 10.1016/j.brainres.2015.12.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.12.051</ArticleId><ArticleId IdType="pmc">PMC4939136</ArticleId><ArticleId IdType="pubmed">26778174</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz A.R., Pinto S., Ezequiel C., Cunha C., Carvalho L.A., Moreira R., Brites D. Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions. Front. Cell Neurosci. 2019;13:109. doi: 10.3389/fncel.2019.00109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00109</ArticleId><ArticleId IdType="pmc">PMC6465643</ArticleId><ArticleId IdType="pubmed">31024256</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo A., Giacoppo S., Bramanti P., Mazzon E. NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model. Inflammation. 2018;41:93&#x2013;103. doi: 10.1007/s10753-017-0667-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-017-0667-5</ArticleId><ArticleId IdType="pubmed">28936769</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin T.C., Wohleb E.S., Zhang Y., Fogaca M., Hare B., Duman R.S. Persistent Increase in Microglial RAGE Contributes to Chronic Stress-Induced Priming of Depressive-like Behavior. Biol. Psychiatry. 2018;83:50&#x2013;60. doi: 10.1016/j.biopsych.2017.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2017.06.034</ArticleId><ArticleId IdType="pmc">PMC6369917</ArticleId><ArticleId IdType="pubmed">28882317</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzm&#xe1;n-Lenis M.S., Navarro X., Casas C. Drug screening of neuroprotective agents on an organotypic-based model of spinal cord excitotoxic damage. Restor. Neurol. Neurosci. 2009;27:335&#x2013;349. doi: 10.3233/RNN-2009-0482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/RNN-2009-0482</ArticleId><ArticleId IdType="pubmed">19738326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Liu Y., Liu X., Li S., Cheng C., Chen S., Le W. Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model. Transl. Neurodegener. 2018;7:35. doi: 10.1186/s40035-018-0138-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-018-0138-4</ArticleId><ArticleId IdType="pmc">PMC6309063</ArticleId><ArticleId IdType="pubmed">30607245</ArticleId></ArticleIdList></Reference><Reference><Citation>Slota J.A., Booth S.A. MicroRNAs in Neuroinflammation: Implications in Disease Pathogenesis, Biomarker Discovery and Therapeutic Applications. Noncoding RNA. 2019;5:35. doi: 10.3390/ncrna5020035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna5020035</ArticleId><ArticleId IdType="pmc">PMC6632112</ArticleId><ArticleId IdType="pubmed">31022830</ArticleId></ArticleIdList></Reference><Reference><Citation>Saura J., Tusell J.M., Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia. 2003;44:183&#x2013;189. doi: 10.1002/glia.10274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.10274</ArticleId><ArticleId IdType="pubmed">14603460</ArticleId></ArticleIdList></Reference><Reference><Citation>Lossi L., Alasia S., Salio C., Merighi A. Cell death and proliferation in acute slices and organotypic cultures of mammalian CNS. Prog. Neurobiol. 2009;88:221&#x2013;245. doi: 10.1016/j.pneurobio.2009.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2009.01.002</ArticleId><ArticleId IdType="pubmed">19552996</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz A.R., Falc&#xe3;o A.S., Scarpa E., Semproni C., Brites D. Microglia Susceptibility to Free Bilirubin Is Age-Dependent. Front. Pharmacol. 2020;11:1012. doi: 10.3389/fphar.2020.01012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01012</ArticleId><ArticleId IdType="pmc">PMC7381152</ArticleId><ArticleId IdType="pubmed">32765258</ArticleId></ArticleIdList></Reference><Reference><Citation>Popko J., Fernandes A., Brites D., Lanier L.M. Automated analysis of NeuronJ tracing data. Cytometry A. 2009;75:371&#x2013;376. doi: 10.1002/cyto.a.20660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.20660</ArticleId><ArticleId IdType="pmc">PMC2661008</ArticleId><ArticleId IdType="pubmed">18937344</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva S.L., Vaz A.R., Di&#xf3;genes M.J., van Rooijen N., Sebasti&#xe3;o A.M., Fernandes A., Silva R.F., Brites D. Neuritic growth impairment and cell death by unconjugated bilirubin is mediated by NO and glutamate, modulated by microglia, and prevented by glycoursodeoxycholic acid and interleukin-10. Neuropharmacology. 2012;62:2398&#x2013;2408. doi: 10.1016/j.neuropharm.2012.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2012.02.002</ArticleId><ArticleId IdType="pubmed">22361233</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>